Swan Lin

5PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 23, 2025
Application of Machine Learning for Predicting Progression-Free and Overall Survival in Patients With Renal Cell Carcinoma.

Caroline W Grant, Jerry Li, Swan Lin

|May 03, 2024
Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults.

Swan Lin, Adrian Ionescu, Jessica Maynard-Scott

|Mar 08, 2022
Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment.

Swan Lin, Jason Gong, George C Canas

|Jan 12, 2022
A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment.

Swan Lin, Jason Gong, George C Canas

|Sep 05, 2020
An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure.

Swan Lin, Naveed Shaik, Geoffrey Chan

Pageof 1

Frequent Collaborators

1 joint publications

David P Walling

1 joint publications

Jaskaran B Singh

1 joint publications

Caroline W Grant

1 joint publications

Jerry Li